The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Amgen
Checkpoint inhibitor (CPI) experienced patients (pts) from COSMUS-1: A clinical observational study of talimogene laherparepvec (T-VEC) in United States practice.
 
Matthew Perez
No Relationships to Disclose
 
Thomas Amatruda
Other Relationship - Amgen
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Charlotte Eielson Ariyan
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
Speakers' Bureau - Bristol-Myers Squibb
 
Anupam M. Desai
No Relationships to Disclose
 
John M. Kirkwood
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Immunocore; Novartis; Roche
Research Funding - Immunocore (Inst); Merck (Inst); Prometheus (Inst)
 
Sheryl Treichel
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Rubina Ismail
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Leon Raskin
Employment - Amgen
Stock and Other Ownership Interests - Amgen